Dexcom Fights Abbott's Bid To Invalidate Its Diabetes Tech IP
Dexcom Inc. has fought back against rival Abbott Laboratories Ltd.'s bid in the High Court to revoke four of its patents for glucose monitoring systems that track blood sugar levels in...To view the full article, register now.
Already a subscriber? Click here to view full article